4.38

1.86% 0.08

After Hours: 4.38

Cytosorbents Corp (CTSO)

Overview News Price History Option Chain Financials Why CTSO Down? Discussions Forecast Stock Split

Cytosorbents Corp stock is traded at $4.38, with a volume of 6,507. It is up +1.86% in the last 24 hours and down -38.36% over the past month. CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Previous Close:

$4.30

Open:

$4.44

24h Volume:

6,507

Relative Volume:

0.56

Market Cap:

$13.80M

Revenue:

$37.20M

Net Income/Loss:

$-11.85M

P/E Ratio:

-22.96

EPS:

-0.1908

Net Cash Flow:

$-10.59M

1W Performance:

-23.83%

1M Performance:

-38.36%

6M Performance:

-67.38%

1Y Performance:

-76.35%

1-Day Range:

$4.33

$4.8275

1-Week Range:

$3.94

$5.79

52-Week Range:

$3.94

$20.40

Cytosorbents Corp Stock (CTSO) Company Profile

Name

Cytosorbents Corp

Sector

Healthcare (1067)

Industry

Medical Devices (139)

Phone

973-329-8885

Address

305 COLLEGE ROAD EAST, PRINCETON, NJ

Employee

129

Twitter

@CytoSorbents

Next Earnings Date

2026-11-12

Latest SEC Filings

CTSO's Discussions on Twitter

Compare CTSO vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTSO Cytosorbents Corp	4.38	13.80M	37.20M	-11.85M	-10.59M	-0.1908
ABT Abbott Laboratories	101.29	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	88.64	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.36	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.92	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.29	49.74B	6.30B	1.07B	1.09B	1.8406

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-07-23	Initiated	B. Riley Securities	Buy
Oct-14-21	Resumed	B. Riley Securities	Buy
Sep-17-20	Initiated	Jefferies	Buy
Sep-01-20	Initiated	SVB Leerink	Outperform
Aug-08-17	Reiterated	Maxim Group	Buy
Oct-26-16	Initiated	Aegis Capital	Buy
May-24-16	Initiated	Maxim Group	Buy
Oct-29-15	Upgrade	WBB Securities	Speculative Buy → Buy
May-12-15	Reiterated	MLV & Co	Buy
Apr-01-15	Reiterated	MLV & Co	Buy
Mar-05-15	Initiated	MLV & Co	Buy
Feb-25-15	Initiated	WBB Securities	Speculative Buy
Jan-27-15	Reiterated	H.C. Wainwright	Buy

View All

Cytosorbents Corp Stock (CTSO) Latest News

Sep 24, 2026

Cytosorbents Corporation (CTSO) stock price, news, quote and history - Yahoo Finance UK

Sep 24, 2026

Sep 23, 2026

CytoSorbents regains Nasdaq $1.00 minimum bid compliance; MVLS shortfall remains under review - TradingView

Sep 23, 2026

Nasdaq keeps CytoSorbents (NASDAQ: CTSO) on watch after $1 bid price return - Stock Titan

Sep 23, 2026

CytoSorbents regains Nasdaq minimum bid price compliance - Investing.com

Sep 23, 2026

Cytosorbents Corporation (CTSO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

CytoSorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement - Moomoo

Sep 23, 2026

Sep 19, 2026